Literature DB >> 25418545

Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy.

Christopher J A Duncan1, Matthias L Schmid, Ulrich Schwab, David A Price, Edmund Ong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25418545     DOI： 10.1097/QAD.0000000000000469

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Authors:  Mary-Ann Davies; Nathan Ford; Helena Rabie; Geoffrey Fatti; Kathryn Stinson; Janet Giddy; Frank Tanser; Karl-Günter Technau; Shobna Sawry; Brian Eley; Robin Wood; Lynne M Mofenson; Olivia Keiser; Andrew Boulle
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

Review 3.  CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Nathan Ford; Kathryn Stinson; Howard Gale; Edward J Mills; Wendy Stevens; Mercedes Pérez González; Mercedes P González; Jessica Markby; Andrew Hill
Journal:  J Int AIDS Soc       Date:  2015-08-07       Impact factor: 5.396

4.  Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods.

Authors:  Ellen F Eaton; Chastity McDavid; Mary Katy Banasiewicz; Michael J Mugavero; Sara J Knight
Journal:  Patient Prefer Adherence       Date:  2017-09-18       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.